CAPSONI, Simona
 Distribuzione geografica
Continente #
NA - Nord America 9.362
AS - Asia 4.355
EU - Europa 2.112
SA - Sud America 679
Continente sconosciuto - Info sul continente non disponibili 249
AF - Africa 116
OC - Oceania 20
Totale 16.893
Nazione #
US - Stati Uniti d'America 9.192
SG - Singapore 1.699
CN - Cina 882
BR - Brasile 527
IT - Italia 526
VN - Vietnam 447
HK - Hong Kong 373
TR - Turchia 301
DE - Germania 272
UA - Ucraina 261
GB - Regno Unito 214
PL - Polonia 185
SE - Svezia 161
BD - Bangladesh 149
JP - Giappone 137
FR - Francia 134
FI - Finlandia 119
RU - Federazione Russa 105
IN - India 98
MX - Messico 72
CA - Canada 71
ID - Indonesia 65
AR - Argentina 49
ZA - Sudafrica 46
IQ - Iraq 45
NL - Olanda 32
EC - Ecuador 25
ES - Italia 22
PH - Filippine 22
CO - Colombia 21
AU - Australia 18
MY - Malesia 17
VE - Venezuela 17
PK - Pakistan 16
UZ - Uzbekistan 15
TN - Tunisia 13
AT - Austria 12
KR - Corea 12
MA - Marocco 12
CL - Cile 11
KE - Kenya 11
SA - Arabia Saudita 11
PY - Paraguay 10
CZ - Repubblica Ceca 9
LT - Lituania 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
SD - Sudan 7
AZ - Azerbaigian 6
BO - Bolivia 6
CH - Svizzera 6
EG - Egitto 6
JM - Giamaica 6
KZ - Kazakistan 6
UY - Uruguay 6
BE - Belgio 5
DZ - Algeria 5
IE - Irlanda 5
IL - Israele 5
IR - Iran 5
CR - Costa Rica 4
GR - Grecia 4
GT - Guatemala 4
NP - Nepal 4
OM - Oman 4
PE - Perù 4
PT - Portogallo 4
TH - Thailandia 4
BG - Bulgaria 3
GY - Guiana 3
HN - Honduras 3
JO - Giordania 3
KH - Cambogia 3
PS - Palestinian Territory 3
RO - Romania 3
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
KG - Kirghizistan 2
KW - Kuwait 2
LY - Libia 2
NZ - Nuova Zelanda 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 16.625
Città #
Ashburn 1.070
Singapore 978
Fairfield 899
Woodbridge 794
Houston 603
San Jose 574
Ann Arbor 436
Chandler 418
Jacksonville 405
Hong Kong 366
Santa Clara 359
Seattle 352
Beijing 304
Cambridge 303
Wilmington 291
Council Bluffs 239
Warsaw 182
Izmir 171
Ho Chi Minh City 151
Los Angeles 134
Tokyo 132
Milan 124
Hanoi 108
Nanjing 108
Boardman 98
Princeton 98
Lauterbourg 96
Dallas 95
New York 92
San Diego 73
The Dalles 60
Rome 55
Ferrara 50
Jakarta 50
São Paulo 47
Chicago 46
Dearborn 45
Addison 41
Nanchang 41
Munich 39
Columbus 38
Falls Church 38
London 35
Mexico City 34
Boydton 31
Orem 31
Phoenix 31
Brooklyn 29
Shenyang 27
Hebei 26
Moscow 26
Shanghai 26
Toronto 26
Denver 24
Des Moines 24
Tianjin 24
Atlanta 23
Chennai 23
Helsinki 23
Jiaxing 23
Rio de Janeiro 23
Mountain View 21
Haiphong 20
Johannesburg 20
San Francisco 20
Stockholm 20
Changsha 19
Bursa 17
Da Nang 17
Redwood City 17
Boston 16
Baghdad 15
Manchester 15
Mumbai 15
Nuremberg 15
Montreal 14
Turin 14
Norwalk 13
Buffalo 12
New Delhi 12
Belo Horizonte 11
Dong Ket 11
Guangzhou 11
Kunming 11
Poplar 11
Cincinnati 10
Hefei 10
Perth 10
Tashkent 10
Cape Town 9
Frankfurt am Main 9
Kuala Lumpur 9
Medellín 9
Quito 9
Amsterdam 8
Ankara 8
Lahore 8
Lanzhou 8
Secaucus 8
Tappahannock 8
Totale 11.612
Nome #
NGF steers microglia toward a neuroprotective phenotype 330
Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen and skeletal muscle dystrophy 314
Environmental enrichment delays the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 248
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 233
Alzheimer-like neurodegeneration in aged antinerve Growth factor transgenic mice 233
Non-human transgenic animals for the study of neurodegenerative syndromes 231
Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis 230
A small molecule targeting the multifactorial nature of Alzheimer's disease 227
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 226
Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice 225
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 221
Dark rearing blocks the developmental down-regulation of brain-derived neurotrophic factor messenger RNA expression in layers IV and V of the rat visual cortex 220
A dual mechanism linking NGF/ProNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 220
Autoradiographic localization of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus 218
Understanding pain perception through genetic painlessness diseases: The role of NGF and proNGF 216
A carnivore species (Canis familiaris) expresses circadian melatonin rhythm in the peripheral blood and melatonin receptors in the brain 211
Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity 208
2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist 202
Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice 201
ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 197
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 190
Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: Mining of microarray data by logic classification and feature selection 189
Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies 187
ProNGF drives localized and cell selective parvalbumin interneuron and perineuronal net depletion in the dentate gyrus of transgenic mice 186
Electrophysiological and behavioral effect of ozone on mice olfactory bulb 186
Neutralization of Nerve Growth Factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone 184
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 182
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease 180
SorLA Deficiency Dissects Amyloid Pathology from Tau and Cholinergic Neurodegeneration in a Mouse Model of Alzheimer's Disease 175
Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration 174
Intranasal "painless" human nerve growth factors slows amyloid neurodegeneration and prevents memory deficits in app x PS1 mice 174
Pathogen-Free Husbandry Conditions Alleviate Behavioral Deficits and Neurodegeneration in AD10 Anti-NGF Mice. 173
Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities 173
A Microglial Function for the Nerve Growth Factor: Predictions of the Unpredictable 172
Intranasal delivery of therapeutic proteins for neurological diseases 172
Cholinergic striatal neurons are increased in HSAN V homozygous mice despite reduced NGF bioavailability 171
Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE 169
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 169
Postnatal development of GFAP in mouse visual cortex is not affected by light deprivation 168
The positional identity of mouse ES cell-generated neurons is affected by BMP signaling 167
Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models 167
Antagonization of NGF in adult mice by transgenic antibodies causes progressive learning and memory impairments 166
Development of a non invasive NGF-based therapy for Alzheimer's disease 164
Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice 162
Characterization of endothelinA receptors in cerebral and peripheral arteries of the rat 161
Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation 161
Nerve growth factor regulates axial rotation during early stages of chick embryo development 159
Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice 159
In vitro receptor binding properties of a "painless" NGF mutein, linked to hereditary sensory autonomic neuropathy type V 157
Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice 156
Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding 156
Rat visual cortical neurones express TrkA NGF receptor 155
Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody 154
Towards non invasive nerve growth factor therapies for Alzheimer's disease 154
Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons 153
In the adult hippocampus, chronic nerve growth factor deprivation shifts GABAergic signaling from the hyperpolarizing to the depolarizing direction 152
Reduction of regional cerebral blood flow by melatonin in young rats 152
Differential regulation of brain-derived neurotrophic factor messenger RNA cellular expression in the adult rat visual cortex 151
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 150
Painless Nerve Growth Factor: A TrkA biased agonist mediating a broad neuroprotection via its actions on microglia cells 149
Melatonin signal transduction and mechanism of action in the central nervous system: Using the rabbit cortex as a model 148
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 147
Endogenous A beta causes cell death via early tau hyperphosphorylation 147
Peripheral Neutralization of Nerve Growth Factor Induces Immunosympathectomy and Central Neurodegeneration in Transgenic Mice 146
Pathogen free conditions slow the onset of neurodegeneration in a mouse model of nerve growth factor deprivation 145
Mismatch between BDNF mRNA and protein expression in the developing visual cortex: the role of visual experience 144
Muscular dystrophy in adult and aged anti-NGF transgenic mice resembles an inclusion body myopathy 142
From genes to pain: nerve growth factor and hereditary sensory and autonomic neuropathy type V 142
Distribution and characterization of the melatonin receptors in the hypothalamus and pituitary gland of three domestic ungulates 138
Graphene Promotes Axon Elongation through Local Stall of Nerve Growth Factor Signaling Endosomes 138
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 137
Characterization by Gene Expression Analysis of Two Groups of Dopaminergic Cells Isolated from the Mouse Olfactory Bulb 137
Non-human transgenic animals for the study of neurodegenerative syndromes 136
Long-term memantine treatment prevents behavioral deficits in a mouse model of sporadic Alzheimer's disease 134
The retina as a window to early dysfunctions of Alzheimer's disease following studies with a 5xFAD mouse model 134
A p75 neurotrophin receptor‐sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microglia 129
Nerve Growth Factor regulates astrocyte physiology in vivo 127
Rescue of the neurodegenerative phenotype in AD11 anti-NGF mice 126
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 126
Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis 125
INIBITORE DI TNF ALPHA ASTROCITARIO PER L’USO NEL TRATTAMENTO DI MALATTIE NEUROLOGICHE 124
Interaction between NH2-tau fragment and Aß in AD mitochondria contributes to the synaptic deterioration 121
Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction 121
Distribution and pharmacological characterization of melatonin receptors in the brain of the Japanese quail (Coturnix japonica) 117
Memoquin: A new therapeutic poly-agent for Alzheimer's disease 114
Muteins of hNGF, therapeutic uses and pharmaceutical compositions 114
Nerve Growth Factor Neutralization Promotes Oligodendrogenesis by Increasing miR-219a-5p Levels 114
Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity 112
Vasoactive intestinal peptide-like immunoreactive fibers in the pineal gland of the sheep 109
Expression of the melatonin receptor in Xenopus laevis: A comparative study between protein and mRNA distribution 109
Unraveling the Role of Dopaminergic and Calretinin Interneurons in the Olfactory Bulb 107
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve growth factor mice 102
Role and Characterization of Dopaminergic Interneurons in Mouse Olfactory Bulbs 100
null 100
Inhibitor of astrocyte TNF alpha for use in the treatment of neurological diseases 100
Enteric Alpha-Synuclein Inclusions, Colonic Inflammation, Increased Mucosal Permeability and Alterations of Bowel Neuromuscular Functions Precede Central Neurodegeneration in a Transgenic Mouse Model of Parkinson's Disease 97
Reversal of neurological deficits by painless nerve growth factor in a mouse model of Rett syndrome 92
Taking pain out of NGF: a "painless" NGF mutant with full neurotrophic activity 91
null 89
Getting Into the Brain: The Intranasal Approach to Enhance the Delivery of Nerve Growth Factor and Its Painless Derivative in Alzheimer’s Disease and Down Syndrome 88
Totale 16.159
Categoria #
all - tutte 77.244
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.244


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022906 0 119 84 33 39 40 61 62 31 81 84 272
2022/20231.036 141 60 12 134 158 124 121 86 123 9 50 18
2023/2024471 53 66 19 20 24 41 10 31 3 32 16 156
2024/20252.158 28 52 171 67 271 167 73 168 314 265 368 214
2025/20266.082 480 296 590 700 797 310 902 307 555 657 297 191
2026/2027448 205 243 0 0 0 0 0 0 0 0 0 0
Totale 16.893